Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2015

Feb 5, 2015

34117_dirs_2015-02-05_af162da5-aa66-455b-92dd-70cd642e0372.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2015-02-05

Reporting Person: Fox Dale (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-05 Employee Stock Option $0.25 D 150000 Disposed 2024-08-08 Common Stock (150000) Direct
2015-02-05 Employee Stock Option $0.103 A 150000 Acquired 2024-08-08 Common Stock (150000) Direct
2015-02-05 Employee Stock Option $0.112 D 300000 Disposed 2025-01-02 Common Stock (300000) Direct
2015-02-05 Employee Stock Option $0.103 A 300000 Acquired 2025-01-02 Common Stock (300000) Direct

Footnotes

F1: Each of the transactions reported in this Form 4 involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the "old" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options.